Increasingly selective pharmacologic targets in cardiovascular disease.
Paoletti
Rodolfo
R
Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. rodolfo.paoletti@unimi.it
Cignarella
Andrea
A
D000368:Aged; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011960:Receptors, Estrogen / Q000819:agonists / Q000378:metabolism*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology* / Q000627:therapeutic use; D054460:rho-Associated Kinases
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D047428:Protein Kinase Inhibitors; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases